Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli

Journal of Endocrinology

Volumn 194, Issue 1, 2007, Pages 213-222

  Sugiyama, Toshihiro ^a,c   Takaki, Toshiaki ^b   Sakanaka, Kenya ^b   Sadamaru, Hiroki ^b   Mori, Koji ^b   Kato, Yoshihiko ^a   Taguchi, Toshihiko ^a   Saito, Takashi ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MINERAL; BONE STRESS; BONE STRUCTURE; COMPUTER SIMULATION; CONTROLLED STUDY; CORTICAL BONE; DRUG MECHANISM; FEMALE; HUMERUS; JUMPING; MECHANICAL STIMULATION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; RIB; SITTING; TIBIA; VERTEBRA;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTICOAGULANTS; BONE AND BONES; BONE DENSITY; COMPUTER SIMULATION; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRACTURES, BONE; MODELS, BIOLOGICAL; MOVEMENT; OSTEOCALCIN; RATS; RATS, INBRED F344; RISK; STRESS, MECHANICAL; TIME FACTORS; WARFARIN;

EID: 34547412484     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-07-0119     Document Type: Article

References (58)

1. Ahmad T, Ohlsson C, Saaf M, Ostenson CG & Kreicbergs A 2003 Skeletal changes in type-2 diabetic Goto-Kakizaki rats. Journal of Endocrinology 178 111-116.
2. Amizuka N, Li M, Hara K, Kobayashi M, Akiyama Y & Maeda T 2005 Histological analysis on altered bone matrix of warfarin-administered rats. Journal of Bone and Mineral Research 20 S194.
3. Binkley N, Krueger D, Engelke J & Suttie J 2007 Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys. Journal of Bone and Mineral Research 22 695-700.
4. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, Wilson PW, Ordovas J, Schaefer EJ, Dawson-Hughes B et al. 2000 Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. American Journal a Clinical Nutrition 71 1201-1208.
5. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P & Karsenty G 1998 Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23 187-196.
6. Boskey AL, Spevak L, Paschalis E, Doty SB & McKee MD 2002 Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcified Tissue International 71 145-154.
7. Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ & Melton LJ, III 1999 a Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporosis International 9 441-448.
8. Caraballo PJ, Heir JA, Atkinson EJ, Silverstein MD, O'Fallon WM, Castro MR & Melton LJ, III 1999b, Long-term use of oral anticoagulants and the risk of fracture. Archives of Internal Medicine 159 1750-1756.
9. Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR & Cummings SR 1999 Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk: the Study of Osteoporotic Fractures. Journal of Bone and Mineral Research 14 1175-1181.
10. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S & Torgerson DJ 2006 Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Archives of Internal Medicine 166 1256-1261.
11. Cowper GR 1966 The shear coefficient in Timoshenko's bearn theory. Journal of Applied Mechanics - Transactions of the ASME 33 335-340.
12. Davidson RT, Foley AL, Engelke JA & Suttie JW 1998 Conversion of dietary phylloquirione to tissue nienaquinone-4 in rats is not dependent on gut bacteria. Journal of Nutrition 128 220-223.
13. Duey P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonacho J, Goldstein S, Gundberg C et al. 1996 Increased bone formation in osteocalcin-deficient mice. Nature 382 448-452.
14. Duvall CL, Taylor WR, Weiss D, Wojtowicz AM & Guldberg RE 2007 Impaired angiogenesis, early caHus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. Journal of Bone and Mineral Research 22 286-297.
15. Eastell R 2006 Does warfarin increase the risk of osteoporotic fracture? Nature Clinical Practice. Endocrinoloyy and Metabolism 2 484-485.
16. Ehrlich PJ & Larryon LE 2002 Mechanical strain and bone cell function: a review. Osteoporosis International 13 688-700.
17. Fratzl P, Gupta HS, Paschalis EP & Roschger P 2004 Structure and mechanical quality of the collagen-mineral nano-composite in bone. Journal of Materials Chemistry 14 2115-2123.
18. Gage BF, Birmari-Deych E, Radford MJ, Nilasena DS & Binder EF 2006 Risk of osteoporotic fracture in elderly patients taking warfarin: results from the national registry of atrial fibrillation 2. Archives of Internal Medicine 116 241-246.
19. Haffa A, Krueger D, Bruner J, Engelke J, Gundberg C, Akhter M & Binkley N 2000 Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. Journal of Bone and Mineral Research 15 872-878.
20. Hara K, Kobayashi M & Akiyama Y 2005 Comparison of inhibirory effects of warfarin on γ-carboxylation between bone and liver in rats. Journal of Bone and Mineral Metabolism 23 366-372.
21. Hirsh J, Foster V, Ansell J & Halperin JL 2003 American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 107 1692-1711.
22. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC & Goldberg HA 1996 Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochemical Journal 317 59-64.
23. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B & Inoue S 2006 Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. Journal of Biological Chemistry 281 16927-16934.
24. 2) and bone quality in the treatment of postmenopausal osteoporosis. Nutrition Reviews 64 509-517.
25. Jamal SA, Browner WS, Bauer DC & Cummings SR 1998 Warfarin use and risk for osteoporosis in elderly women. Annals of Internal Medicine 128 829-832.
26. Kanis JA 2002 Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359 1929-1936.
27. Knapen MHJ, Hellemons-Boode BSP, Langenberg-Ledeboer M, Knottnerus JA, Hamulyak K, Price PA & Vermeer C 2000 Effect of oral anticoagulant treatment on markets for calcium and bone metabolism. Haemostasis 30 290-297.
28. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, Kivela SL & Vaananen HK 2000 Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. Journal of Bone and Mineral Research 15 2473-2478.
29. Mamdani M, Upshur RE, Anderson G, Bartle BR & Laupacis A 2003 Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 23 1-4.
30. Matsumoto M & Nishimura T 1998 Mersenne twister: a 623-dimensionally equidistributed uniform pseudo-random number generator. ACM Transactions on Modeling and Computer Simulation 8 3-30.
31. 1) by osteoblasts and osteoblast like cells: role of heparan sulfate proteoglycans and apolipoprotein E. Journal of Bone and Mineral Research 17 426-433.
32. Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, Hata K, Fukumoto S & Matsumoto T 1997 Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. Journal of Clinical Endocrinology and Metabolism 82 2915-2920.
33. Petyr M 1998 Introduction to Finite Element Vibration Analysis, Cambridge: Cambridge University Press.
34. Poole KES & Compston JE 2006 Osteoporosis and its management. BMJ 333 1251-1256.
35. Price PA & Williamson MK 1981 Effects of warfarin on bone: studies on the vitamin K-dependent protein of rat bone. Journal of Biological Chemistry 256 12754-12759.
36. 1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporosis International 17 1122-1132.
37. Rejnmark L, Vestergaard P & Mosekilde L 2007 Fracture risk in users of oral anticoagulants: a Nationwide Case-control Study. International Journal of Cardiolcgy 118 338-344.
38. Ronden JE, Drittij-Reijnders MJ, Vermeer C & Thijssen HH 1998 Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochimica et Biophysica Acta 1379 69-75.
39. Russo CR, Lauretani E Seeman E, Bartali B, Bandinelli S, Di lorio A, Guralink J & Ferrucci L 2006 Structural adaptations to bone loss in aging men and women. Bone 38 112-118.
40. Schilling AF, Schinke T, Munch C, Gebauer M, Niemeier A, Priemel M, Streichert T, Rueger JM & Amling M 2005 Increased bone formation in mice lacking apolipoprotein E. Journal of Bone and Mineral Research 20 274-282.
41. Schcofs MW, van der Klift M, Hofman A, van Duijn CM, Stricker BH, Pols HA & Uitterlinden AG 2004 ApoE gene polyrmorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study. Journal of Bone and Mineral Research 19 1490-1496.
42. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM & Cummings SR 2001 Older women with diabetes have an increased risk of fracture: a Prospective Study. Journal of Clinical Endocrinology aud Metabolism 86 32-38.
43. Seeman E & Delmas PD 2006 Bone quality: the material and structural basis of bone strength and fragility. New England Journal of Medicine 354 2250-2261.
44. Simon RR, Beauciin SM, Johnston M, Walton KJ & Shaughnessy SG 2002 Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats. Thrombosis Research 105 353-358.
45. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB & Newman AB 2005 Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Archives of Internal Medicine, 165 1612-1617.
46. Sugiyama T 2007 Possible involvements of vitamin K in bone quality. Archives of Internal Medicine 167 93-94.
47. Sugiyama T & Kawai S 2004 Quantitative ultrasound, skeletal quality, and fracture risk. Lancet 363 1076-1077.
48. Sugiyama T, Taguchi T & Kawai S 2002 a Adaptation of bone to mechanical loads. Lancet 359 1160.
49. Sugiyama T, Yamaguchi A & Kawai S 2002 b Effects of skeletal loading on bone mass and compensation mechanism in bone: a new insight into the 'mechanostat' theory. Journal of Bone and Mineral Metabolism 20 196-200.
50. 12 for hip fracture prevention after stroke. JAMA 294 792.
51. Szulc P, Chapuy MC, Meunier PJ & Delmas PD 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. Journal of Clinical Investigation 91 1769-1774.
52. Szulc P, Chapuy MC, Meunier PJ & Delmas PD 1996 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a Three Year Follow-up Study. Bone 18 487-488.
53. Turner CH & Burr DB 2001 Experimental techniques for bone mechanics. In Bone Mechanics Handbook, pp 7.1-7.35. Ed. SC Cowin. Boca Raton: CRC Press.
54. Umemura Y, Ishiko T, Yamauchi T, Kurono M & Mashiko S 1997 Five jumps per day increase bone mass and breaking force in rats. Journal of Bone and Mineral Research 12 1480-1485.
55. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K & Delmas PD 1997 Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. Journal of Clinical Endocrinology and Metabolism 82 719-724.
56. 2) improved bone strength through modification of hydroxyapatite crystals in NIDDM rats. Journal of Bone and Mineral Research 15 S309.
57. Weaver W Jr, Timoshenko SP & Young DH 1990 Vibration Problems in Engineering., Mississauga: John Wiley & Sons, Inc.
58. WHO Scientific Group 2003 Prevention and Management of Osteoporosis: WHO Technical Report Series No. 921. Geneva: World Health Organization.